Acuta Capital Partners’s Alector ALEC Stock Holding History

Acuta Capital Partners’s Portfolio ALEC Stock Details ALEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200,000	Closed	-$3.74M	–	31
2019 Q1	$3.74M	Buy	+200,000	New	+$3.78M	1.78%	21

Other funds holding ALEC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Acuta Capital Partners's ALEC Position: Q2 2019 in Review

Acuta Capital Partners sold out of Alector (ALEC) in Q2 2019, closing a stake of 200,000 shares — an estimated $3.74M sold.

Acuta Capital Partners first reported a position in ALEC in Q1 2019 and held it in 1 quarter. The position peaked at $3.74M in Q1 2019. 63 funds tracked by Wall St. Rank hold ALEC as of Q2 2019.

Acuta Capital Partners reported no remaining Alector position as of Q2 2019 after selling out during the quarter.
Acuta Capital Partners sold 200,000 Alector shares in Q2 2019, an estimated $3.74M.
Acuta Capital Partners first reported a position in Alector in Q1 2019 and held it in 1 quarter.
Acuta Capital Partners's Alector position peaked at $3.74M in Q1 2019.
63 funds tracked by Wall St. Rank held Alector as of Q2 2019.

Based on Acuta Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.